Trial site
University of California Los Angeles (UCLA).
- 29running trials
- 16closed trials
The trials here
What the 45 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer5 trials
- Acute myeloid leukaemia3 trials
- Endometrial cancer3 trials
- Epilepsy3 trials
- Glioblastoma3 trials
- Head and neck cancer3 trials
- Multiple myeloma3 trials
- Ovarian cancer3 trials
- Pancreatic cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Bladder cancer2 trials
- Childhood cancers2 trials
- and 27 more
- Phase
- Phase 1/211 trials
- Phase 311 trials
- Phase 27 trials
- Phase 2/33 trials
- Phase 12 trials
- Phase 41 trial
- Status
- Recruiting12 trials
- Active, not recruiting11 trials
- Terminated9 trials
- Completed7 trials
- Not yet recruiting4 trials
- Enrolling by invitation2 trials
- Lead sponsor
- Regeneron Pharmaceuticals4 trials
- University of California, Los Angeles4 trials
- Janssen Research & Development, LLC2 trials
- AlloVir1 trial
- AMO Pharma Limited1 trial
- and 33 more
Running trials
Recruiting
A Phase I Clinical Study of YN003 in the Treatment of Glioma
Recruiting
Not yet recruiting
Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
Enrolling by invitation
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
Recruiting
Active, not recruiting
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Active, not recruiting
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Myotonic dystrophy2 recruiting
- Prostate cancer2 recruiting
- Brain aneurysm1 recruiting
- Depression1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Epilepsy1 recruiting
- Fabry disease1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Long COVID and ME/CFS1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Stroke1 recruiting
Closed trials
Terminated
Study of ART0380 in Patients With Biologically Selected Solid Tumors
Terminated
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
Terminated
Terminated
Completed
Completed
Transcranial Direct Current Stimulation (tDCS) Therapy in Major Depression
Terminated
A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
Terminated
Terminated
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
Completed
Terminated
Completed
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Terminated
A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies
Completed
Completed
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026